COVID-19 vaccines

Ángela Bernardo made this Informationsfreiheit request to Europäische Arzneimittel-Agentur

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

Es ist ein Übermittlungsfehleroder ähnliches aufgetreten, welcher von unserem AsktheEU.org Team repariert werden muss.

Dear European Medicines Agency,

Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am requesting documents which contain the following information:

- Correspondence (including emails and their attachments) involving officials/representatives from the European Medicines Agency and all the national competent authorities of the Member States of the European Union (EU) and the European Economic Area (EEA) responsible for human medicines which refer to the issue of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca).

- Correspondence (including emails and their attachments) involving officials/representatives from the European Medicines Agency and all the national competent authorities of the Member States of the European Union (EU) and the European Economic Area (EEA) responsible for human medicines which refer to the issue of COVID-19 Vaccine Janssen.

- Data related to the cases of unusual blood clots with low blood platelets found after the administration of any of the authorised COVID-19 vaccines in the Member States of the European Union (EU) and the European Economic Area (EEA), including information regarding gender and age of the people affected by these unusual events.

Yours faithfully,

Ángela Bernardo

Europäische Arzneimittel-Agentur

2 Attachments

Delivery has failed to these recipients or groups:

[1]documents requests at EMA ([EMA request email])
The email address you entered couldn't be found. Please check the
recipient's email address and try to resend the message. If the problem
continues, please contact your helpdesk.

Diagnostic information for administrators:

Generating server: wv1278.emea.eu.int

[EMA request email]
Remote Server returned '550 5.1.1 RESOLVER.ADR.RecipNotFound; not found'

Original message headers:

Received: from wv1275.emea.eu.int (172.16.91.20) by wv1278.emea.eu.int
(172.16.91.23) with Microsoft SMTP Server (TLS) id 15.0.1497.2; Tue, 27 Apr
2021 19:59:34 +0200
Received: from mail6.bemta26.messagelabs.com (172.16.40.221) by
wv1275.emea.eu.int (172.16.91.20) with Microsoft SMTP Server (TLS) id
15.0.1497.2 via Frontend Transport; Tue, 27 Apr 2021 19:59:34 +0200
Return-Path: <[FOI #9389 email]>
Received: from [100.113.2.110] (using TLSv1.2 with cipher DHE-RSA-AES256-GCM-SHA384 (256 bits))
by server-3.bemta.az-a.eu-central-1.aws.symcld.net id 86/D1-41911-50158806; Tue, 27 Apr 2021 17:59:33 +0000
Authentication-Results: mx.messagelabs.com; spf=pass
(server-23.tower-225.messagelabs.com: domain of asktheeu.org designates
46.43.39.108 as permitted sender) smtp.mailfrom=asktheeu.org; dkim=none
(message not signed); dmarc=none (no record) header.from=asktheeu.org
X-Brightmail-Tracker: H4sIAAAAAAAAA+NgFvrNLMWRWlGSWpSXmKPExsWip62eo8sa2JF
gsOoas0Xv3tNsDowe71uesQcwRrFm5iXlVySwZrzc9Ii94J9gxdrTZg2Mm/m7GLk4hASOM0ps
e3WNrYuRg4NFQFWieS1nFyMnB5tAsMSO/9NZQWwRASOJ5cs7mUBsXgFziTn/z7CA2MICFhKv3
y5jAmnlFRCU+LtDGCTMLKAhcXTDDRYIW1ti2cLXzBMYOWchVM1CUjULSdUCRuZVjBZJRZnpGS
W5iZk5uoYGBrqGhsa6RrqmhnqJVbqJeqmlusmpeSVFiUBJvcTyYr3iytzknBS9vNSSTYzAcEg
pZDLewXjt9Qe9Q4ySHExKorzz5rcnCPEl5adUZiQWZ8QXleakFh9ilOHgUJLg1QjoSBASLEpN
T61Iy8wBhiZMWoKDR0mEN84fKM1bXJCYW5yZDpE6xajLcfP9kkXMQix5+XmpUuK89SBFAiBFG
aV5cCNgcXKJUVZKmJeRgYFBiKcgtSg3swRV/hWjOAejkjBvI8glPJl5JXCbXgEdwQR0xLLzbS
BHlCQipKQamIKW3RBJ+LJRe/VkPU23BZt2nzbRbt5r7LvKm5FVR0BxpaKknUZMHffUIuuf1ld
Zph5/wDhHZ89s0a0sZkLPXUSsJ7pf9GVxTvGbu8/wiazl80uq0kkCO6/4hF19wq3I7HHQVtrg
kaqETsP3G2fKvRPVhD7lnw7z0+6dvO1pKu+d+7tuqF3r3327MH/q4rnZJ12yKrVLvwfYrDoer
7hw6r3/kpKHF33XWac6b0/Yt5NZ82uLQx6uFfl55OeiJPZtE20ZF9yrsLz8uth+y/XjP+y6vl
Td273So+/W40jmQ1anJ2+XtdSc7GCiHOLLzhm88Avf+sMGHy96TPr/P6Ny7S5zzVibK8Wz5xp
eTRCcvk+JpTgj0VCLuag4EQBVDAR1DgMAAA==
X-Env-Sender: [FOI #9389 email]
X-Msg-Ref: server-23.tower-225.messagelabs.com!1619546372!100698!1
X-Originating-IP: [46.43.39.108]
X-SpamReason: No, hits=0.0 required=7.0 tests=newsletters:
X-StarScan-Received:
X-StarScan-Version: 9.75.3; banners=-,-,-
X-VirusChecked: Checked
Received: (qmail 20031 invoked from network); 27 Apr 2021 17:59:33 -0000
Received: from owl.ukcod.org.uk (HELO owl.ukcod.org.uk) (46.43.39.108)
by server-23.tower-225.messagelabs.com with ECDHE-RSA-AES256-GCM-SHA384 encrypted SMTP; 27 Apr 2021 17:59:33 -0000
Received: from foieu by owl.ukcod.org.uk with local (Exim 4.89)
(envelope-from <[FOI #9389 email]>)
id 1lbRzg-00048S-5A
for [EMA request email]; Tue, 27 Apr 2021 18:59:32 +0100
Date: Tue, 27 Apr 2021 18:59:32 +0100
From: =?UTF-8?B?w4FuZ2VsYSBCZXJuYXJkbw==?=
<[FOI #9389 email]>
To: documents requests at EMA <[EMA request email]>
Message-ID: <[email address]>
Subject: access to documents request - COVID-19 vaccines
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

References

Visible links
1. mailto:[EMA request email]